Pharmacokinetics and Pharmacodynamics of DMPA With HIV PrEP

Summary

This study is a biphasic steady state pharmacokinetic and pharmacodynamic study of TFV and FTC in healthy women comparing the drug levels and activity in the absence (first phase) and then the presence (second phase) of DMPA. The investigators will recruit 12 healthy women aged 18-45 who are HIV-negative and at low risk for acquiring HIV.

Timeline

Start

2017-11-17

Primary completion

2018-04-18

Completion

2020-12-01

Drugs

Indications